Atlas Trials

A Study to Evaluate the Efficacy of FK949E in Bipolar Disorder Patients With Major Depressive Episodes

Clinical trial NCT01725308 · COMPLETED

Trial details

NCT number
NCT01725308
Sponsor
Astellas Pharma Inc
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Bipolar Disorder
Start date
2012-02-07
Primary completion
2015-08-01
Enrollment
431

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.